Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists

Medicines are a highly regulated category of commodities that demand strict oversight across their distribution chains and face numerous challenges in ensuring safety and authenticity. In response to concerns about counterfeit products, gray-market diversion, and pressures to protect public insuranc...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhuo Zhao, Haozheng Wang, Junyi Zhai, Zheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1619916/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850067475775881216
author Zhuo Zhao
Zhuo Zhao
Zhuo Zhao
Haozheng Wang
Haozheng Wang
Junyi Zhai
Junyi Zhai
Zheng Wang
Zheng Wang
author_facet Zhuo Zhao
Zhuo Zhao
Zhuo Zhao
Haozheng Wang
Haozheng Wang
Junyi Zhai
Junyi Zhai
Zheng Wang
Zheng Wang
author_sort Zhuo Zhao
collection DOAJ
description Medicines are a highly regulated category of commodities that demand strict oversight across their distribution chains and face numerous challenges in ensuring safety and authenticity. In response to concerns about counterfeit products, gray-market diversion, and pressures to protect public insurance funds, China has rapidly advanced a nationwide drug traceability policy, mandating unit-level digital identifiers and requiring point-of-dispensing scanning by 1 July 2025. However, given China’s vast territory, substantial regional disparities, and complex healthcare infrastructure, this accelerated policy rollout has posed considerable challenges for frontline implementation, placing significant pressure on outpatient pharmacy operations. In high-volume tertiary hospitals, where prescription volumes are exceptionally large, the manual scanning of traceability codes has markedly increased dispensing times, prolonged patient waiting, and heightened pharmacist workloads, further complicated by inconsistent barcode placement and hardware limitations. To explore potential solutions, our team developed and evaluated a machine vision–based scanning prototype under laboratory conditions. The system demonstrated meaningful workflow improvements in simulated dispensing scenarios and holds promise for future validation and adaptation in real-world settings. Drawing on our experiences as frontline pharmacists, this study provides practical observations from a tertiary hospital in Northwestern China, examining dispensing processes before and after traceability code integration. We hope these findings contribute to international dialogue on pharmaceutical management, helping to advance medication safety, governance, and equitable access in healthcare systems worldwide.
format Article
id doaj-art-810b6c6d746a49d690f69116a336f178
institution DOAJ
issn 1663-9812
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-810b6c6d746a49d690f69116a336f1782025-08-20T02:48:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-07-011610.3389/fphar.2025.16199161619916Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacistsZhuo Zhao0Zhuo Zhao1Zhuo Zhao2Haozheng Wang3Haozheng Wang4Junyi Zhai5Junyi Zhai6Zheng Wang7Zheng Wang8Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaClinical Research Center of Shaanxi Province for Dental and Maxillofacial Diseases, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaState Key Laboratory for Manufacturing System Engineering, Xi’an Jiaotong University, Xi’an, ChinaKey Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaMedical Insurance Administration Office, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaKey Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaMedical Quality and Safety Management Office, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaKey Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaDepartment of Pharmacy, College of Stomatology, Xi’an Jiaotong University, Xi’an, ChinaMedicines are a highly regulated category of commodities that demand strict oversight across their distribution chains and face numerous challenges in ensuring safety and authenticity. In response to concerns about counterfeit products, gray-market diversion, and pressures to protect public insurance funds, China has rapidly advanced a nationwide drug traceability policy, mandating unit-level digital identifiers and requiring point-of-dispensing scanning by 1 July 2025. However, given China’s vast territory, substantial regional disparities, and complex healthcare infrastructure, this accelerated policy rollout has posed considerable challenges for frontline implementation, placing significant pressure on outpatient pharmacy operations. In high-volume tertiary hospitals, where prescription volumes are exceptionally large, the manual scanning of traceability codes has markedly increased dispensing times, prolonged patient waiting, and heightened pharmacist workloads, further complicated by inconsistent barcode placement and hardware limitations. To explore potential solutions, our team developed and evaluated a machine vision–based scanning prototype under laboratory conditions. The system demonstrated meaningful workflow improvements in simulated dispensing scenarios and holds promise for future validation and adaptation in real-world settings. Drawing on our experiences as frontline pharmacists, this study provides practical observations from a tertiary hospital in Northwestern China, examining dispensing processes before and after traceability code integration. We hope these findings contribute to international dialogue on pharmaceutical management, helping to advance medication safety, governance, and equitable access in healthcare systems worldwide.https://www.frontiersin.org/articles/10.3389/fphar.2025.1619916/fulldrug traceability codes in China healthcare policy implementationdrug traceability codeoutpatient pharmacistreal-world experienceChina
spellingShingle Zhuo Zhao
Zhuo Zhao
Zhuo Zhao
Haozheng Wang
Haozheng Wang
Junyi Zhai
Junyi Zhai
Zheng Wang
Zheng Wang
Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
Frontiers in Pharmacology
drug traceability codes in China healthcare policy implementation
drug traceability code
outpatient pharmacist
real-world experience
China
title Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
title_full Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
title_fullStr Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
title_full_unstemmed Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
title_short Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists
title_sort comprehensive promotion of drug traceability codes in china in 2025 challenges and solutions for tertiary outpatient pharmacists
topic drug traceability codes in China healthcare policy implementation
drug traceability code
outpatient pharmacist
real-world experience
China
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1619916/full
work_keys_str_mv AT zhuozhao comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT zhuozhao comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT zhuozhao comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT haozhengwang comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT haozhengwang comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT junyizhai comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT junyizhai comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT zhengwang comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists
AT zhengwang comprehensivepromotionofdrugtraceabilitycodesinchinain2025challengesandsolutionsfortertiaryoutpatientpharmacists